skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins

Abstract

The disclosure relates to nucleic acids mosaic clade M HIV-1 Env polypeptides and to compositions and vectors comprising same. The nucleic acids are suitable for use in inducing an immune response to HIV-1 in a human.

Inventors:
; ; ; ; ;
Issue Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1410329
Patent Number(s):
9821053
Application Number:
14/689,995
Assignee:
Duke University (Durham, NC); Los Alamos National Security, LLC (Los Alamos, NM); The UAB Research Foundation (Birmingham, AL); Beth Israel Deaconess Medical Center (Boston, MA)
Patent Classifications (CPCs):
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
DOE Contract Number:  
AC52-06NA25396
Resource Type:
Patent
Resource Relation:
Patent File Date: 2015 Apr 17
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Korber, Bette T., Fischer, William, Liao, Hua-Xin, Haynes, Barton F., Letvin, Norman, and Hahn, Beatrice H. Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins. United States: N. p., 2017. Web.
Korber, Bette T., Fischer, William, Liao, Hua-Xin, Haynes, Barton F., Letvin, Norman, & Hahn, Beatrice H. Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins. United States.
Korber, Bette T., Fischer, William, Liao, Hua-Xin, Haynes, Barton F., Letvin, Norman, and Hahn, Beatrice H. Tue . "Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins". United States. https://www.osti.gov/servlets/purl/1410329.
@article{osti_1410329,
title = {Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins},
author = {Korber, Bette T. and Fischer, William and Liao, Hua-Xin and Haynes, Barton F. and Letvin, Norman and Hahn, Beatrice H.},
abstractNote = {The disclosure relates to nucleic acids mosaic clade M HIV-1 Env polypeptides and to compositions and vectors comprising same. The nucleic acids are suitable for use in inducing an immune response to HIV-1 in a human.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2017},
month = {11}
}

Patent:

Save / Share:

Works referenced in this record:

Polyvalent immunogen
patent-application, August 2003


Polyvalent immunogen
patent-application, January 2004


Polyvalent Vaccine
patent-application, December 2009


HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
journal, November 2002


A New Variant Cytotoxic T Lymphocyte Escape Mutation in HLA-B27-Positive Individuals Infected with HIV Type 1
journal, May 2005


Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
journal, October 2000


Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
journal, February 2010


Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys
journal, July 2003


Human Immunodeficiency Virus-Specific Responses in Adult Ugandans: Patterns of Cross-Clade Recognition
journal, March 2005


HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway
journal, December 2002


Prospects for an AIDS vaccine
journal, March 2004


HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response
journal, June 2005


Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
journal, December 2006


Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities
journal, February 2004


The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years
journal, September 2005


Diversity Considerations in HIV-1 Vaccine Selection
journal, June 2002


Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins
journal, September 2009


Codon usage limitation in the expression of HIV-1 envelope glycoprotein
journal, March 1996


DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice
journal, February 1998


Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
journal, January 2014


Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes
journal, December 2005


Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response
journal, November 2004


Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
journal, December 2004


Clonal breadth of the HIV-1-specific T-cell receptor repertoire in vivo as determined by subtractive analysis
journal, January 2005


Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination
journal, December 2008


Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines
journal, November 2003


Evolutionary and immunological implications of contemporary HIV-1 variation
journal, September 2001


T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces
journal, May 2009


T Cell Cross-Reactivity and Conformational Changes during TCR Engagement
journal, December 2004


A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses
journal, September 2006


Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load
journal, March 2004


HIV VACCINES
journal, December 2005


CD8+ T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef
journal, September 2005


Urgently needed: a filter for the HIV-1 vaccine pipeline
journal, August 2004


HIV vaccine strategies
journal, February 2002


Fine Specificity and Cross-Clade Reactivity of HIV Type 1 Gag-Specific CD4+ T Cells
journal, March 2004


HIV‐Specific Cellular Immune Response Is Inversely Correlated with Disease Progression as Defined by Decline of CD4+ T Cells in Relation to HIV RNA Load
journal, April 2004

  • Oxenius, Annette; Price, David A.; Hersberger, Martin
  • The Journal of Infectious Diseases, Vol. 189, Issue 7, p. 1199-1208
  • https://doi.org/10.1086/382028

Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity
journal, January 2006


Recombination in HIV-1
journal, March 1995


A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys
journal, July 2008


Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
journal, February 2010


Use of T Cell Epitopes for Vaccine Development
journal, November 2001


Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes
journal, February 1999


Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice
journal, September 2004


The Role of T Cell Antagonism and Original Antigenic Sin in Genetic Immunization
journal, December 2002


Toward an AIDS Vaccine
journal, May 2008


Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env Immunogen
journal, June 2006


Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development
journal, February 2003